1,8-Naphthyridine-2-nonanoic acid, 5,6,7,8-tetrahydro-α-[[(tetrahydro-4-methyl-2H-pyran-4-yl)carbonyl]amino]-, (αS)-;PLN-1474;(2S)-2-[(4-methyloxan-4-yl)formamido]-9-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)nonanoic acid;PLN-1474, 10 mM in DMSO
PLN-1474 is a selective and orally active αvβ1 integrin inhibitor (IC50 < 50 nM) that significantly reduces hepatic pSMAD3/SMAD3 levels, liver collagen gene expression, and hepatic hydroxyproline (OHP) concentration in a mouse model of liver fibrosis; it can be used for the prevention, delay, or investigation of fibrotic or cirrhotic diseases or disorders.